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ORIGINAL ARTICLE
Nitrite enhances liver graft protection against cold ischemia reperfusion
injury through a NOS independent pathway
Amani Cherif-Sayadi a*, Kaouther Hadj Ayed-Tkaa*, Mohamed Amine Zaoualia,b, Mohamed Bejaouia,
Najet Hadj-Abdallahb, Ahlem Bouhlelb and Hassen Ben Abdennebia
aResearch Unit of Biology and Molecular Anthropology Applied to Development and Health (UR12ES11), Faculty of Pharmacy, University
of Monastir, Monastir, Tunisia; bHigh Institute of Biotechnology of Monastir, University of Monastir, Monastir, Tunisia
ABSTRACT
Introduction: Nitrite has been found to protect liver graft from cold preservation injury. However,
the cell signaling pathway involved in this protection remains unclear. Here, we attempt to clarify
if the NOS pathway by using the NOS inhibitor, L-NAME (L-NG-Nitroarginine methyl ester).
Animals and methods: Rat livers were conserved for 24 h at 4°C in (IGL-1) solution enriched
or not with nitrite at 50 nM. In a third group, rats were pretreated with 50 mg/kg of L-NAME
before their liver procurement and preservation in IGL-1 supplemented with nitrite (50 nM)
and L-NAME (1 mM). After 24 h of cold storage, rat livers were ex-vivo perfused at 37°C during
2 h. Control livers were perfused without cold storage.
Results: Nitrite effectively protected the rat liver grafts from the onset of cold I/R injury.
L-NAME treatment did not abolish the beneficial effects of nitrite. Liver damage, protein
oxidation and lipid peroxidation remained at low levels in both nitrite-treated groups when
compared to IGL-1 group. Antioxidant enzyme activities and functional parameters were
unchanged after NOS inhibition.
Conclusion: Despite NOS inhibition by L-NAME, nitrite can still provide hepatic protection
during cold I/R preservation. This suggests that nitrite acts through a NOS-independent
pathway.
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It is well established that an ischemia/reperfusion (I/
R) injury, inherent to cold preservation, is the main
cause of primary dysfunction and primary non-func-
tion of liver allograft [1]. In fact, the steps of organ
transplantation, from graft harvest to graft revascu-
larization, contribute to enhance organ susceptibility
to an I/R injury and further increase tissue vulner-
ability towards injuries. One of the aforementioned
steps is organ preservation in which the goal is to
maintain the functional, biochemical and morpholo-
gical integrity of the graft. Various hypothermic pre-
servation solutions have been formulated to
maintain cell viability during ischemia and to allow
their early functional resumption on reoxygenation.
Although institut Georges Lopez (IGL-1) liquid
extends graft viability, severe organ injury is quite
common with prolonged cold storage, and graft
dysfunction after transplantation still occurs at sig-
nificant rates. So, improvement of the composition of
preservation solution is fundamental to optimize the
outcome of liver transplantation (LT).
Several studies have demonstrated that nitric oxide
(NO) effectively protected grafts from the onset of an
I/R injury [2–4]. NO is able to induce vasodilatation
and so to improve graft revascularization [4]. It could
reduce platelet aggregation and leukocytes adhesion
which limits inflammatory damage during I/R insult
[5,6]. It regulates interleukins and others inflammatory
mediators’ release [7]. More recently, it has been
reported that NO could modulate autophagy and
apoptosis [8]. In addition, we have demonstrated
that the activation of the endothelial nitric oxide
synthase (eNOS) and the production of NO by this
enzyme increased liver graft preservation and
improve liver function after reperfusion [9–11].
Previous reports have also shown that tissue damage
during the early phase of reperfusion appears to be
associated with decreased NO availability related to
eNOS down-regulation [12]. Taken these facts into
account, several teams have sought to optimize the
composition of the storage solutions by their supple-
mentation with exogenous source of NO [7,13]. In this
sense, the use of nitrite therapy as exogenous source
of NO proved to be an useful tool to protect organ
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function and integrity from any I/R damage, such as
those encountered in organ transplantation [14].
In our recent report, we confirmed that enrichment
of IGL-1 preservation solution with nitrite improved
liver graft preservation [15]. However, the pathway by
which nitrite mediates its hepatocellular protection
remains controversial. Some authors suggested that
nitrite activity is dependent on NO production but
independent from eNOS activity [14,16,17], whereas
others showed that NO production is dependent from
eNOS activation [3,9]. Duranski et al. showed that
nitrite induced a cardioprotective effect in eNOS-defi-
cient mice submitted to warm I/R demonstrating thus
that NO protection is independent from eNOS [14].
The main purpose of the present study was to
examine whether the NOS pathway is involved in the
protective effect of nitrite against a cold I/R injury in




Male Sprague-Dawley rats weighting between 250
and 300 g were used. Animals were housed under
periodic cycle of 12 h of light/dark and they had
free access to water and rat food. This experimental
protocol was performed according to European Union
regulations for animal experiments (Directive 86/609
CEE) and after agreement of local ethical committee.
Liver extraction and ex vivo perfusion
Rats were anesthetized with an intraperitoneal injec-
tion of urethane (5%). Livers were harvested as
described previously [11]. Briefly, after cannulation of
the common bile duct, livers were flushed, by cold
preservative solution, through a catheter introduced
into the aorta. After cooling, a second catheter was
inserted into the portal vein to complete organ rin-
sing and the whole liver was excised and trimmed of
surrounding tissues. Then, extracted livers were con-
served in 50 mL of preservative solution in a herme-
tically closed container, for 24 h at 4°C.
After cold preservation, livers were maintained dur-
ing 20 min at ambient temperature in order to mitigate
the rewarming phase in liver graft transplantation.
Next, livers were rinsed with 10 mL of Ringer’s lactate
solution and immediately connected to ex-vivo perfu-
sion circuit. Time point 0 min corresponds to the collec-
tion of rinse solution effluent which coincides with the
connection of the portal catheter to the circuit. Livers
were then perfused at 37°C via the portal vein in a
closed and controlled pressure circuit. The flow was
progressively increased over the first 15-min in order
to stabilize the portal pressure at 12 mm Hg (Pression
Monitor BP-1; Pression Instruments, Sarasota, FL). The
flow was controlled by a peristaltic pump (Minipuls 3;
Gilson, France).
After 120 min of normothermic perfusion, vena
cava effluent and tissue specimens were collected
for biochemical determinations.
Experimental groups
Rats were randomly divided into 4 experimental
groups (n = 6 for each):
● Control: After procurement, livers were ex-vivo
perfused for 120 min as described above without
prior cold storage.
● IGL-1: Livers were preserved in IGL-1 storage
solution for 24 h and then perfused ex-vivo at
37°C during 120 min.
● IGL-1 + Nitrite: Same as IGL-1 group but IGL-1
preservation solution was supplemented with
nitrite at 50 nM.
● IGL-1 + Nitrite + NAME: 30 min before liver
procurement, L-NAME (50 mg/kg) was injected
through the vena cave [4]. Then, livers were
flushed and preserved in cold IGL-1 solution
supplemented with 50 nM of nitrite and 1 mM
of L-NAME [4]. After cold preservation, livers
were ex-vivo perfused at 37°C during 120 min.
Liver damage evaluation
In order to evaluate liver injury, we measured the aspar-
tate aminotransferase (AST) and alanine aminotransfer-
ase (ALT) activities in the effluent of rinse solution (time
corresponding to 0-min reperfusion) and in the effluent
of perfusion solution (time corresponding to 120-min
reperfusion). Transaminase activities were determined
spectrophotometrically with commercial kit according
to provider’s indications (Biomerieux, France).
Gamma-glutamyl transferase (GGT) and alkaline
phosphatase (PAL) are associated with hepatocellular
damage [18,19]. They were measured in liver effluents
after 120-min reperfusion, by an UV spectrophotometer
at 410 and 405 nm, respectively (Siemens, France).
Bile flow
Liver function was assessed by measuring bile produc-
tion during 120-min reperfusion. Bile was collected
through the cannulated common bile duct, and out-
put was reported as μL/min/g of liver [11,20].
Vascular resistance
Vascular resistance is calculated according to the fol-
lowing formula: Vascular resistance = Portal pressure/





























portal flow, and expressed as mL/min/g of liver. Portal
pressure was fixed at 12 mm Hg during the 120-min
perfusion and portal flow was controlled by a peristal-
tic pump.
Malondialdehyde assay
Malondialdehyde (MDA) is an indicator of membrane’s
lipid peroxidation induced by oxidative stress which
generates oxygen species. MDA is measured in hepatic
tissue by means of thiobarbituric acid test [11,20].
Sulfhydryl and carbonyl proteins assays
Sulfhydryl compounds (PSH) are scavengers of reac-
tive oxygen species [21,22] whereas protein carbonyls
are produced consecutively to lipid peroxidation but
essentially to glyco and protein-oxydation after oxida-
tive stress [23]. PSH were assayed by Ellman’s test
using DTNB (5,5’-Dithionitrobenzoic acid) and mea-
sured spectrophotometrically at 412 nm [24,25].
Carbonyl proteins were measured spectrophotometri-
cally at 350 and 375 nm after derivatization in pre-
sence of 2,4-dinitrophenylhydrazine (DNPH) [23,26].
Antioxidant enzymes activities in the hepatic
tissue
The total superoxide dismutase (Cu-Zn SOD and Mn
SOD) activity was assessed by following the inhibition
of pyrogallol oxidation according to the method of
Marklund and Marklund [27]. It was measured at
420 nm and expressed as U/mg protein (one unit of
SOD was defined as the enzyme amount causing 50%
inhibition of pyrogallol oxidation).
The catalase (CAT) activity was assessed by the
method of Claiborne [28], which consists of following
the decomposition rate of H2O2 spectrophotometrically
at 240 nm [28]. It was expressed as µmol of decomposed
H2O2/min/mg of protein.
We also appraised the activity of glutathione per-
oxidase (GPx) and the rate of glutathione (GSH) fol-
lowing Flohe and Gunzler reaction by measuring the
reduction of the absorbance of GSH at 412 nm in
presence of H2O2 [29,30]. GSH was expressed as µg/
mg of protein and GPx activity was expressed as µmol
GSH/min/mg of protein.
Statistical analysis
Results were expressed as mean values ± standard
errors (SEM). Differences between groups were exam-
ined for statistical significance using Kruskal – Wallis
non parametric test followed by Dunn’s multiple com-
parison test (Graph Pad Prism software, version 6 for
Windows). Data was considered statistically significant
as p-value <0.05.
Results
We conducted these experiments to explore whether
NOS inhibition could influence the anti ischemic effect
of nitrite. As shown in Figures 1 and 2, significant
reduction of ALT and AST activities were observed in
IGL-1 + Nitrite group both before and after nor-
mothermic ex vivo reperfusion as compared to IGL-1
group (p < 0.05, respectively). Regarding ALT, we
observed 27.8 ± 2.5 vs 89.7 ± 2.7 U/L (p < 0.05) before
reperfusion (Figure 1 A). For AST, we found 44 ± 8 vs
221 ± 28 U/L (p < 0.05) at 0 min (Figure 1(b)). After
120 min of reperfusion, we found 90.6 ± 5.5 vs
388.1 ± 51.6 U/L (p < 0.05) for ALT (Figure 2(a)) and
157.6 ± 31.1 vs 323.8 ± 47.8 U/L (p < 0.05) for AST
(Figure 2(b)). Concerning GGT activity, we found
8.30 ± 0.11 vs 7.07 ± 0.14 U/L for IGL-1 and IGL-1 +









































































Figure 1. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities in liver effluent obtained after 24 h of
cold preservation (a, b). Livers’ rat (n = 6) were flushed and preserved in IGL-1 solution (4°C for 24 h) supplemented with 50 nM
of nitrite or with 50 nM of nitrite + 1 mM of L-NAME (L-NG-Nitroarginine methyl ester). Sham: livers were flushed and perfused
ex vivo without cold storage. Data are expressed as means ± SE (n = 6 for each group). a: p < 0.05 vs Sham; b: p < 0.05 vs IGL-1.





























PAL activity, we detected 14.5 ± 0.5 vs 11.5 ± 0.5 for
IGL-1 and IGL-1 + Nitrite groups, respectively
(p < 0.05, (Figure 2(d)). About IGL-1 + Nitrite +
L-NAME group, we noted for ALT: 30 ± 28 U/L and
109 ± 31 U/L at respectively 0 min and 120 min; for
AST: 51 ± 33 U/L and 116 ± 23 U/L at respectively
0 min and 120 min; for GGTand PAL at 120 min:
7.35 ± 0.01 U/L and 12.01 ± 0.01 U/L, respectively.
No statistical differences were found between IGL-1 +
Nitrite and IGL-1 + Nitrite + L-Name groups for ALT
and AST activities at both 0 min and 120 min of
reperfusion.
Nitrite was also found to protect hepatic function.
This is evidenced by the improvement of bile flow
(6.41 ± 0.07 vs 36.01 ± 7.22 µL/min/g for IGL-1 and
IGL-1 + Nitrite groups respectively, p < 0.05) (Figure 3
(a)), as well as the attenuation of portal resistance
(3.54 ± 0.18 vs 0.85 ± 0.11 mm Hg.min/mL/g for IGL-
1 and IGL-1 + Nitrite groups respectively, p < 0.05)
(Figure 3(b)). The use of L-NAME didn’t induce signifi-
cant changes in any of these parameters as compared
to IGL-1 + nitrite group. Actually, we noted
46.04 ± 2.43 µL/min/g for bile flow and
1.08 ± 0.10 mm Hg.min/mL/g for portal resistance.
The next step of the study explored the relation-
ship between oxidative stress, nitrite and NOS. We
found that, comparing with IGL-1 group, nitrite sup-
plementation markedly reduced lipid and protein oxi-
dation as attested by lower levels of MDA (3.28 ± 0.32
vs 1.35 ± 0.28 nmol/mg protein, respectively, p < 0.05)
(Figure 4(a)) and of carbonyl proteins (0.36 ± 0.06 vs
0.17 ± 0.01 nmol/mg protein, respectively, p < 0.05)
(Figure 4(b)) on one hand, and a higher level of PSH
(3.64 ± 0.42 vs 7.19 ± 0.17 μg/mg protein, respectively,
p < 0.05) (Figure 4(c)), on the other hand. In line with
this, livers stored in IGL-1 + nitrite solution exhibited a
marked rise of the activity of antioxidant enzymes
catalase (221.05 ± 3.34 μmol H2O2/min/mg protein)
(Figure 5(a)), GPx (24.16 ± 1.10 μmol GSH/min/mg
protein) (Figure 5(b)), SOD (4.73 ± 0.42 U/mg protein)
(Figure 5(c)) and of GSH level as well (0.65 ± 0.07 μg/
mg protein) (Figure 5(d)) when referred to those con-
served in IGL-1 (177 ± 3.4 μmol H2O2/min/mg protein,
5.44 ± 0.36 μmol GSH/min/mg protein, 3.53 ± 0.22 U/
mg protein, 0,37 ± 0.07 μg/mg protein, respectively).
Upon L-NAME association to nitrite, no statistical
changes were found in the hepatic oxidative status
as compared to nitrite alone. We noted
1.09 ± 0.05 nmol/mg protein for MDA,
0.06 ± 0.01 nmol/mg protein for carbonyl proteins,
8.24 ± 1.17 μg/mg protein for PSH, 236.09 ± 7.38 μmol




















































































































































Figure 2. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities in liver effluent obtained after 24 h of
cold preservation and 120 min of normothermic reperfusion (a, b), Gamma-glutamyl transferase (G-GT) (c), and alkaline
phosphatase (PAL) (d) after of normothermic reperfusion. Livers’ rat (n = 6) were flushed and preserved in IGL-1 solution (4°
C for 24 h) supplemented with 50 nM of nitrite or with 50 nM of nitrite + 1 mM of L-NAME (L-NG-Nitroarginine methyl ester).
Sham: livers were flushed and perfused ex vivo without cold storage. Data are expressed as means ± SE (n = 6 for each group).
a: p < 0.05 vs Sham; b: p < 0.05 vs IGL-1.





























min/mg protein for GPx, 4.81 ± 0.47 U/mg protein for
SOD and 0,57 ± 0.01 μg/mg protein for GSH.
Discussion
An Ischemia-reperfusion injury associated to liver sur-
gery remains until now an unresolved problem.
Damages are caused by warm ischemia during graft
procurement and implementation, cold ischemia during
preservation and reperfusion [4]. All of these steps are
unavoidable during LT. Many groups are focusing of
strategies reducing I/R injury in order to limit primary
graft dysfunction or non-function [31]. Otherwise, it is
widely valued that I/R associated with LT induces
endothelial insult characterized by marked trouble in
NO homeostasis [9,16,32]. The decrease in NO bioavail-
ability appears early after reperfusion, and seems to be

















































































































Figure 3. Bile output (a) and portal resistance (b), after 120 min of normothermic reperfusion. Livers’ rat (n = 6) were flushed
and preserved in IGL-1 solution (4°C for 24 h) supplemented with 50 nM of nitrite or with 50 nM of nitrite + 1 mM of L-NAME (L-
NG-Nitroarginine methyl ester). Sham: livers were flushed and perfused ex vivo without cold storage. Data are expressed as





































































































































Figure 4. Lipid peroxidation expressed as malondialdehyde (MDA) activity (a), carbonyl proteins (Prot Carb) (b), and sulfhydryl
proteins (PSH) levels (c) in liver tissues after normothermic reperfusion. Livers’ rat (n = 6) were flushed and preserved in IGL-1
solution (4°C for 24 h) supplemented with 50 nM of nitrite or with 50 nM of nitrite + 1 mM of L-NAME (L-NG-Nitroarginine
methyl ester). Sham: livers were flushed and perfused ex vivo without cold storage. Data are expressed as means ± SE (n = 6 for
each group). a: p < 0.05 vs Sham; b: p < 0.05 vs IGL-1.





























the inactivation of NO by the overproduction of super-
oxide anion, or both. It is largely appreciated that eNOS
activation induces liver protection [33].
In the present study, we aimed to determine if the
NOS pathway is involved in the protective effect of
nitrite against cold I/R injury in isolated liver by using
the NOS inhibitor, L-NAME. We found that nitrite sup-
plementation to IGL-1 solution at 50 nM improves all
biochemical, oxidative stress and functional para-
meters of the liver graft, and that L-NAME addition
to nitrite enriched IGL-1 solution didn’t abolish the
protective effect of nitrite whereas Name addition to
IGL-1 solution without nitrite didn’t shown any signif-
icant results from IGL-1 group (results are not shown).
These results suggest that nitrite could act through an
independent NOS pathway. Our results are in accor-
dance with those of Wei Li et al. demonstrating that
the use of nitrite induced protection against cold I/R
injury in liver graft [34]. Also, they support Duranski
et al. hypothesis [14] stating that nitrite induces its
protecting issues on liver and heart through a path-
way independent from eNOS. This team has reported
that nitrite remains cytoprotective even in eNOS-defi-
cient mouse and the effect is dependent on NO pro-
duction. Nevertheless, other authors found that nitrite
did not protect against renal I/R injury [35].
The strongest data supporting the thesis that nitrite
could serve as an important source of endocrine NO
appear from studies of I/R although the precise mechan-
ism of how it induces tissue protection is still misleading.
Endogenous NO is synthesized from L-arginine in an
oxidation reaction, catalyzed by the NOS enzymes [3].
This complex reaction requires the presence of co-sub-
strates O2 and the reduced form of nicotinamide ade-
nine dinucleotide phosphate, as well as many cofactors
including flavin adenine dinucleotide, flavin mononu-
cleotide and tetrahydrobiopterin . In vivo, nitrite is con-
sidered as a catabolism product of NO. Indeed, NO is
inactivated primarily by superoxide anion, but other
pathways could be implicated. The first one is related
to the autoxidation of NO to nitrite and then to nitrate.
Other pathways may be mediated by metal-catalyzed
oxidation reactions. The copper-containing protein cer-
uloplasmin (P-Cu2+) has been found to quickly oxidize
NO to nitrite in physiological conditions. Besides to the
P-Cu2+-mediated reaction, ferrous deoxygenated hemo-
globin rapidly converts NO to nitrate [36,37]. However
during ischemic condition, some investigations have
emphasized the ability for nitrite to serve as a biological
precursor of NO in the vascular compartment. This
allowed some studies to demonstrate that nitrite can
protect or reverse tissue damage during ischemia, espe-
cially in settings characterized by loss of NO bioavail-
ability such those encountered during cold preservation
of organs. Nitrite is reduced to NO during hypoxia and


























































































































































































Figure 5. Evaluation of antioxidant enzymes catalase (CAT) (a), glutathione peroxidase (GPX) (b), superoxide dismutase (SOD)
(c), reduced gluthatione (GSH) (d) activities. Livers’ rat (n = 6) were flushed and preserved in IGL-1 solution (4°C for 24 h)
supplemented with 50 nM of nitrite or with 50 nM of nitrite + 1 mM of L-NAME (L-NG-Nitroarginine methyl ester). Sham: livers
were flushed and perfused ex vivo without cold storage. Data are expressed as means ± SE (n = 6 for each group). a: p < 0.05 vs
Sham; b: p < 0.05 vs IGL-1.





























oxidoreductase (XOR) and by heme proteins such as
deoxyhemoglobin, myoglobin, and tissue heme [38–
40]. The L-NAME has been shown, in vitro and in vivo,
to be potent inhibitor of NOS and the production of NO
[41]. Therefore, our results suggest that nitrite action
would be mediated through these ischemia-activated
pathways and not through NOS activation.
Taken together, our results show that nitrite may
be an efficient additive to cold preservation solution
to fill up the losses of NO and to correct NO disorders
associated with organ storage. The mechanism of
action of nitrite seems to be independent from NOS
pathway.
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